INTRODUCTION
Fragile X syndrome, the most common form of inherited mental retardation with an estimated prevalence of one in 4000 males and one in 8000 females, is typically caused by a massive CGG trinucleotide repeat expansion within the 5 0 -untranslated region (UTR) of the fragile X mental retardation 1 gene (FMR1), which results in transcriptional silencing of FMR1 (1) (2) (3) (4) . The identification of other mutations (e.g. deletions in patients with the typical phenotype) has confirmed that FMR1 is the only gene involved in the pathogenesis of fragile X syndrome (5-7); loss of the FMR1 product, fragile X mental retardation protein (FMRP), causes fragile X syndrome.
FMRP and its autosomal paralogs, the fragile X-related proteins FXR1P and FXR2P, constitute a well-conserved, small family of RNA-binding proteins (fragile X-related gene family) that share more than 60% amino acid identity and contain two types of RNA-binding motifs: two ribonucleoprotein K homology domains (KH domains) and a cluster of arginine and glycine residues (RGG box) (8, 9) . FMRP is known to form a messenger ribonucleoprotein (mRNP) complex that associates with translating polyribosomes. It has been proposed that FMRP plays a role in synaptic plasticity via the regulation of mRNA transport and translation (10) . Furthermore, the cumulative work of several groups now suggests that FMRP may regulate the translation of its mRNA through miRNA interactions. In one likely scenario, once FMRP binds to its specific mRNA ligands, it then recruits the RNA-induced silencing complex (RISC) along with miRNAs and facilitates recognition between miRNAs and their mRNA ligands. Thus, FMRP could modulate the efficiency of translation of its mRNA targets using miRNAs (11) . It has also been shown that the loss of Fmrp can alter the proliferation and differentiation of embryonic neural stem cells in mice (12) ; however, up to now the role of FMRP in the maintenance and fate specification of stem cells has not been explored.
Unlike their mammalian counterparts, the fly genome harbors a single Fmr1 gene homolog, also referred to as dFmr1 or dfxr (dFmr1 here, per FlyBase annotation). Sequence comparisons show a high level of similarity between the functional domains of fly and mammalian Fmrp, with an overall 56% similarity and 35% identity (13, 14) . Given the power of Drosophila genetics to elucidate biological pathways, over the last few years, the fruit fly has proved enormously useful for exploring the physiological roles of FMRP. Whereas homozygous dFmr1 mutant adult flies appear morphologically normal, they display abnormalities in behavior, synaptogenesis and spermatogenesis, phenotypes that resemble some of those observed in fragile X patients (13, (15) (16) (17) (18) (19) (20) . In Drosophila ovary, a very small population of germline stem cells (GSCs) is maintained in a well-defined microenvironment (i.e. the stem niche at the tip of each ovariole). This environment provides an attractive system for investigating the regulatory mechanisms that determine stem cell fate [see review (21) for details] (21, 22) . Previous studies have shown that dFmr1 is involved in germ cell and oocyte specification; however, whether dFmr1 is required for controlling the fate of GSCs has remained unknown (23, 24) .
Here, we use Drosophila GSCs as a model to show that FMRP can modulate the fate of stem cells. We demonstrate that dFmr1 is required for both GSC maintenance and repressing differentiation. Furthermore, we show that dFmrp interacts with Argonaute protein 1 (AGO1), a key component of the miRNA pathway, to modulate the fate of GSCs. These results support the notion of a conserved role for translational control in the regulation of stem cell function, revealing a new function for FMRP in stem cells.
RESULTS
The loss of dFmr1 leads to defects in germline stem cell maintenance and/or establishment Given that the GSC in Drosophila ovary is a well-defined system for studying the regulatory mechanisms that determine stem cell fate, we chose to explore the potential role of dFmr1 in GSCs. A typical Drosophila ovary is composed of 16 -20 ovarioles. Each ovariole consists of an anterior functional unit, called germarium, and a linear string of differentiated egg chamber posterior to the germarium. At the tip of the germarium, GSCs normally divide asymmetrically to ensure that one daughter cell remains attached to the niche cells for selfrenewal, while the other is displaced from the niche, becoming a cystoblast (CB) that initiates differentiation and sustains oogenesis (25) . In a previous study, two null alleles of dfmr1 were generated, namely dfmr1 Delta50 and dfmr1 Delta113 , both of which exhibited sterility in males and weak fertility in females (13, 26) . Using Hoechst staining for nuclei, we found that seven-day-old germaria from adult dfmr1
Delta113 mutants displayed morphological abnormalities (Fig. 1A and C) . Approximately, 50% of dfmr1 mutant germaria were morphologically normal when compared with wild-type. Nevertheless, whereas approximately 40% of germaria appeared normal, they were attaching with only fewer egg chambers (one or two), rather than the normal six or seven. In some cases, the germaria were completely empty. This phenotype hinted at defects in GSC maintenance and/or establishment.
dFmr1 is required for both germ stem cell maintenance and repressing primordial germ cell differentiation
To address whether dFmr1 is required for GSC maintenance, we examined the number of GSCs in germaria from dfmr1 mutant flies at different ages. The ovaries from both newly eclosed and seven-day-old dfmr1 mutant females were tested by staining with anti-Vasa and anti-Hts antibodies. Vasa staining can specifically visualize all germ cells during oogenesis, while Hts is preferentially rich in fusome, a germ cell-specific organelle that is morphologically spherical in primordial germ cells (PGC) and GSCs/cystoblasts, but branched in differentiated cysts. GSCs can be reliably recognized at the tip of the germarium by their position of direct contact with cap cells or base cells of the terminal filament and the anterior localization of spherical fusomes (also called spectrosomes) (21) . In wild-type females, a typical germarium has an average of two to three GSCs (Fig. 1B) . In contrast, as shown in Table 1 , the newly eclosed dfmr1 homozygous germaria contained an average of 0.88 (dfmr1 Delta113 / dfmr1 Delta113 ) and 0.81 (dfmr1 Delta113 /dfmr1 Delta50 ) GSCs per germarium. Among them, 17.5-21.4% have two GSCs, 45.5 -46% contain one GSC and 30.4-34.1% have only differentiated cysts or an empty germarium. In the seven-day-old dfmr1 homozygous germaria, the number of GSCs was reduced to an average of 0.58 (dfmr1
Delta113

/dfmr1
Delta113 ) and 0.37 (dfmr1 Delta113 /dfmr1 Delta50 ) per germarium, suggesting that the loss of dFmr1 causes either the progressive loss of GSCs or a defect in GSC maintenance ( Fig. 1D -F) . To further exclude the possibility that the observed phenotype was due to genetic background, we examined the number of GSCs in different combinations of dfmr1 null allele with deficiency line Df(3R)BSC38. We observed that the newly eclosed dfmr1 homozygous germaria contained an average of 0.99 (n ¼ 57) [dfmr1 Delta113 /Df(3R)BSC38] and 1.01
Delta50 /Df(3R)BSC38] GSCs per germarium, whereas, in the same condition, wild-type (w 1118 ) germaria contained an average of 2.6 (n ¼ 99) GSCs per germarium. These results together suggest that dFmr1 is required for GSC maintenance.
To address whether dFmr1 is involved in GSC establishment, we examined PGCs from dfmr1 gonads. PGCs are the precursors of germ cells and are known to be controlled by similar signaling pathways as adult GSCs (27) . During the three larval stages, the number of PGCs is simply multiplied from 12 cells to more than 100 cells, but without further differentiation into the female gonad (28) . To determine whether PGCs can differentiate in a dfmr1 background, we used anti-Hts and anti-Vasa antibodies to stain wild-type and dfmr1 mutant gonads. As shown in Figure 2A , most wild-type gonads from late third-instar larvae exhibited PGCs carrying a single spherical fusome, and some of the PGCs were dividing with two spherical fusomes associated between two PGC cells. However, we observed that 76.7% (n ¼ 43) of dfmr1 mutant gonads contained differentiated PGC clusters that were marked by branched fusomes (Fig. 2B -D) . This suggests that dFmr1 is required to repress PGC differentiation and is probably involved in the transition from PGCs to GSCs. Based on these findings, we conclude that dFmr1 is required to repress both PGC and GSC differentiation. dFmr1 modulates the fate of germline stem cells as an extrinsic factor
The loss of GSCs in dFmr1 mutant ovaries indicates a requirement for dFmr1 in either GSCs or somatic cells (or both). To test how dFmr1 modulates the GSC fate, we first examined the expression pattern of dFmrp in germarium. As shown in Figure 3A , using immunostaining with anti-dFmrp antibody, we found that dFmrp is ubiquitously expressed in both germ cells and somatic cells, suggesting that dFmrp could function in either cell type. To analyze whether dFmrp functions as a cell-autonomous factor for maintaining GSC fate, we used an FLP-FRT-mediated mitotic recombination technique to generate marked mutant GSCs, then calculated the life span of the marked mutant GSCs by quantifying their loss rate. The marked mutant GSCs were identified by a lack of GFP fluorescence in the nuclei and by their positions directly attaching to the base cells of the terminal filament or cap cells. The dFmr1 loss-of-function alleles (dfmr1 Delta113 and dfmr1
Delta50
) were used to generate marked mutant GSC clones for an analysis of dFmr1 function in GSCs. The rates of Ubi-GFP-marked GSCs were measured at 2, 7 and 14 days after 5-day heat-shock treatment (AHST). As shown in Table 2 , compared with wildtype (w 1118 ) control GSC clones, the marked clone rates of both dfmr1
Delta113 and dfmr1 Delta50 were not significantly reduced during the tested period. These findings suggest that dFmr1 is required extrinsically for GSC maintenance (Fig. 4) .
To further explore whether dFmr1 is involved in controlling the rate of GSC division, we examined the ability of dFmr1 mutant GSC producing cysts. At Day 14 after heat-shock induction, a wild-type GSC clone produced an average of 2.9 (n ¼ 35) germline cysts, similarly, for dfmr1
Delta113 and dfmr1
Delta50 mutant GSCs, averages of 2.4 and 2.9 cysts were produced per mutant GSC, respectively, suggesting that dFmr1 is not involved in controlling the rate of GSC division.
dFmr1 biochemically and genetically interacts with Ago1 in Drosophila ovary
The necessity of dFmr1 for GSC maintenance indicates a novel mechanism for GSC fate determination. Extensive studies of FMRP in both Drosophila and mammals suggest that FMRP functions as a translational repressor (11) . Recently, FMRP was also shown to be associated with the RISC in both mammals and Drosophila (29 -31). In Drosophila, genetic studies have suggested that Ago1, as a key component of the miRNA pathway, is critical for dFmrp function in neural development and synaptogenesis (29) . These data indicate that FMRP could use the miRNA pathway to regulate the translation of its specific mRNA targets. To explore how dFmr1 is involved in GSC maintenance, we examined whether dFmr1 interacts with Ago1 in the Drosophila ovarian GSC system. We performed co-immunoprecipitation (IP) experiments using anti-Ago1 antibody and ovary lysates. As shown in Figure 3B , dFmrp (approximately 85 kDa) could be co-immunoprecipitated with Ago1 from ovary lysates. To confirm that the association is specific, we performed a reciprocal IP experiment, and Ago1 (approximately 120 kDa) could be co-immunoprecipitated with dFmrp as well. These results suggest that Ago1 is specifically associated with dFmrp in Drosophila ovary.
To further test whether dFmr1 genetically interacts with Ago1 for the maintenance of germline cells, we quantified the number of GSCs in dfmr1 (dfmr1 Delta113 /dfmr1 Delta50 ) mutant and Ago1
Delta50 mutant germaria. Interestingly, we found that the loss of one copy of Ago1 could enhance the dfmr1 phenotype in GSCs. For example, in three-day-old dfmr1 germaria, the average number of GSCs was 0.73 (n ¼ 58), whereas for age-matched dfmr1 homozygotes, which have lost one copy of Ago1
), the average number of GSCs was 0.60 (n ¼ 44), suggesting that Ago1 and dFmr1 may potentially function in the same genetic pathway to coordinate the regulation of GSC fate. These combined results indicate that dFmrp may function together with Ago1 to modulate the fate of GSCs.
DISCUSSION
Fragile X syndrome, the most common cause of inherited mental retardation, results from the loss of functional FMRP (32). Since the FMR1 gene was first cloned in 1991, most studies have been focusing in understanding how the loss of FMRP leads to mental retardation in the nervous system. FMRP is an RNA-binding protein and is known to bind to specific mRNAs and regulate their translation both in vitro and in vivo. FMRP is largely cytoplasmic, incorporated into large mRNP particles (11) . It has been proposed that FMRP plays a role in synaptic plasticity via the regulation of mRNA transport and translation, particularly local protein synthesis in the dendrites (33) . A growing body of work from several groups now suggests that the microRNA pathway is the major molecular mechanism by which FMRP regulates translation. In both Drosophila and mammals, FMRP, as well as its autosomal homologs in mammals, FXR1P and FXR2P, has been found to be a part of the RISC (29 -31) . However, it remains unclear what role, if any, FMRP plays in siRNA-mediated gene silencing. In the miRNA pathway, FMRP has been associated with miRNAs in both Drosophila and mammals, and the genetic interaction between dFmr1 and Ago1 has already been demonstrated in Drosophila. Therefore, FMRP is one component of the miRNA pathway involved in miRNA-mediated translational control. Recently, FXR1P has also been shown to work with AGO2 to activate the cell growth-dependent translation (34) . Whether FMRP is involved in this process remains to be determined.
Whereas Fmrp has already been shown to alter the proliferation and differentiation of embryonic neural stem cells in mice, the role of FMRP in the maintenance and fate specification of stem cells had not been explored (12) . In Drosophila, dFmr1 is required for cyst formation and oocyte specification, potentially via the regulation of Orb mRNA translation (23) . Our report provides the first evidence that in Drosophila, dFmr1 as an RNA-binding protein is required for the maintenance of GSCs, which suggests that FMRP could be involved in the division and self-renewal of adult stem cells. The importance of translational regulation to the self-renewal and differentiation of stem cells has been recognized, due to the discovery of important roles for other RNA-binding proteins, Delta113 was not significantly reduced during the tested period (Table 2) .
including Pum and Nos, in GSC regulation (22) . Our findings provide further evidence that translational regulation plays pivotal roles in stem cell regulation.
The question becomes how dFmr1 controls the maintenance of GSCs in Drosophila. Given that FMRP is a translational regulator, it is very likely that dFmr1 protein could regulate the translation of specific mRNAs in GSCs that are critical for the differentiation of adult stem cells. Identifying those mRNAs regulated by dFmrp in Drosophila GSCs would be revealing and significant. Given that dFmrp is a component of the miRNA pathway involved in miRNA-mediated translational control, our present finding is also consistent with the recent discovery that the miRNA pathway plays critical roles in the maintenance of GSCs (35 -37) . On the other hand, earlier studies have demonstrated that dFmrp/Fmrp and the tumor suppressor protein lethal (2) giant larvae (Lgl) can form a functional complex in flies and mice (38) . This Fmrp/Lgl complex is regulated by the PAR protein complex. Furthermore, both Lgl and the PAR protein complex have been implicated in the control of cell polarity, which is necessary for the self-renewal and differentiation of stem cells (39) . So it is also possible that, besides regulating the translation of specific mRNAs in GSCs via the miRNA pathway, dFmrp may also work with Lgl and the PAR complex to control the maintenance of stem cells.
In short, we have discovered a new role for dFmrp in stem cells. It will be important to determine whether in mammals FMRP can modulate stem cells, particularly neural stem cells, given the neurological phenotypes associated with fragile X syndrome. Studying the role of FMRP in stem cells will not only facilitate further understanding of the molecular pathogenesis of fragile X syndrome, but also improve our understanding of the role translational control plays in the maintenance and fate specification of stem cells in general, a prerequisite for any therapeutic application of stem cells for human diseases.
MATERIALS AND METHODS
Drosophila genetics
All flies were maintained under standard culture conditions. dfmr1
Delta113 and dfmr1 Delta50 (gifts from Dr Y. Zhang) were null dfmr1 alleles as described previously (13) . Ago1 k08121 has also been described (40) . The deficiency line Df(3R)BSC38 came from Bloomington Stock Center.
Immunohistochemistry and microscopy
Ovaries were prepared for reaction with antibodies as described previously (41) . Polyclonal anti-Vasa antibody (Santa) was used at a 1:200 dilution, and monoclonal anti-Hts antibody was used at a 1:500 dilution. Secondary antibodies used were goat anti-mouse Alexa 568, goat anti-rabbit Alexa 488 and goat anti-rat Cy3 (Molecular Probes), all at 1:200. All samples were examined by Zeiss Microscope, and images were captured using the Zeiss Two Photon Confocal LSM510 META system. Images were further processed with Adobe Photoshop 6.0.
Phenotypic assay for quantification of germline stem cell maintenance in mutant adult ovaries Ovaries isolated from wild-type and homozygous mutant flies of different ages were incubated with anti-Hts antibody, antiVasa antibody and DNA dyes to identify terminal filament cells, fusomes and germ cells. We scored as GSCs any Vasapositive germ cells at the anterior position that appeared close to cap cells or to the basal cells of terminal filaments and also carried spherical fusomes at the anterior position or extending fusomes.
Germline clonal analysis
FLP -FRT-mediated recombination was used to generate dFmr1 mutant GSC and PGC clones. To generate GSC clones, three-day-old females, w; hs-flp; FRT82B,ubi-gfp/ FRT82B,dfmr1
2 , underwent heat-shock treatment at 378C for 60 min twice daily at 12 h intervals (w; hs-flp; FRT82B, ubi-gfp/FRT82B as control). After 4 -5 days of heat-shock induction monitored by GSC clone efficiency of control, ovaries were dissected for quantification of GSC clones at Day 2, Day 7 and Day 14 of the post-clonal induction. The percentage of GSC clones measured at Day 2 was also calculated as the initial rate (100 of relative %). GSC clones were identified by a lack of GFP fluorescence in the nucleus and carrying anterior-positioned dot fusome (spectrosome).
Immunoprecipitation and western blot analysis
Fly ovaries were collected and homogenized in 1 ml ice-cold lysis buffer (10 mM Tris, pH 7.4, 150 mM NaCl, 30 mM EDTA, 0.5% Triton X-100) with 2Â complete protease inhibitors. All further manipulations of the ovary lysates were performed at 48C or on ice. Nuclei and debris were pelleted at 10 000g for 10 min; the supernatant was collected and precleared for 1 h with 100 ml recombinant protein G agarose (Invitrogen). Antibody against either dFmr1 protein or Ago1 was incubated with recombinant protein G agarose at 48C for 2 h and washed three times with lysis buffer. The precleared lysates were immunoprecipitated with antibody-coated recombinant protein G agarose at 48C overnight. The precipitated complexes were used for western blot analysis. For western blotting, antibody was used at a dilution of 1:1000. Anti-rabbit or -mouse secondary antibodies were horseradish peroxidase (Amersham Biosciences, formerly Amersham Pharmacia Biotech, Inc.) conjugated and detected by Enhanced ChemiLuminescence (Amersham Biosciences, formerly Amersham Pharmacia Biotech, Inc.).
